Cyberounds Logo
September 23, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Genetic Counseling in a Patient with BRCA2 Gene Mutation
CME credit is no longer available for this conference.
Dharmen Patel, M.D., Lawrence R. Shapiro, M.D., and Robert G. Lerner, M.D.

Dr. Dharmen Patel was a Fellow at Westchester Medical Center who is now in private practice in Mt. Carmel, TN and Dr. Lawrence Shapiro is Professor of Pediatrics at New York Medical College and Director, Regional Medical Genetics Center, Westchester Medical Center.

Drs. Patel and Shapiro report no commercial conflicts of interest. In the past three years, Dr. Lerner has served as a consultant for GlaxoSmithKline and has served on the Speakers' Bureau for Pharmacia.

Release Date: 10/25/2002
Termination Date: 10/25/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the risk of breast cancer in a patient with BRCA gene mutations
  • Discuss the risk of ovarian cancer in a patient with BRCA gene mutations
  • Discuss the role of prophylactic bilateral salpingo-oophorectomy in a woman with BRCA gene mutations
  • Discuss the importance of genetic testing and counseling in a patient with a strong family history of breast and ovarian cancer.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity